New drugs known as direct oral anticoagulants (DOACs) used to treat serious blood clots are associated with reduced risks of major bleeding compared with the older anti-clotting drug, warfarin, finds a new study.
Source: sd

LEAVE A REPLY

Please enter your comment!
Please enter your name here